Origin Materials (ORGN) Director Reports 36,155-Share RSU Grant
Rhea-AI Filing Summary
Origin Materials, Inc. (ORGN) director John Hickox reported the acquisition of 36,155 shares of Common Stock on 09/30/2025. These shares represent restricted stock units (RSUs) granted in lieu of cash compensation for the quarter ended September 30, 2025, calculated using the closing price of $0.5186 on that date. Each RSU converts to one share and the RSUs were fully vested at grant, but the reporting person elected to defer receipt to a future date. After the reported transaction, Hickox beneficially owns 836,156 shares. The Form 4 was signed on 10/01/2025 by an attorney-in-fact.
Positive
- 36,155 RSUs granted representing compensation rather than cash, aligning director pay with shareholder interest
- RSUs fully vested at grant, giving the reporting person an immediate contingent right to shares
- Beneficial ownership disclosed: reporting person holds 836,156 shares following the transaction
Negative
- Issuance of 36,155 shares increases outstanding share count and may cause dilution (amount disclosed in filing)
Insights
TL;DR: Routine director RSU election increases insider ownership by 36,155 shares; non-cash compensation converted and deferred.
The filing documents a standard non-employee director compensation election where 36,155 RSUs were received in lieu of cash and are fully vested at grant. The grant price used was the closing share price of $0.5186 on 09/30/2025. The reporting person elected to defer delivery of the underlying shares, so immediate share count impact is through beneficial ownership reporting (836,156 shares). This is a customary governance and compensation event with limited immediate market impact.
TL;DR: Compensation election follows policy; vested RSUs deferred, reflecting standard director compensation mechanics.
The disclosure indicates the issuer's Amended and Restated Non-Employee Director Compensation Policy was used to convert cash fees to RSUs. The RSUs are described as fully vested upon grant but subject to a Deferral Election Form, which delays share issuance while recording beneficial ownership. The Form 4 is properly executed and signed by an attorney-in-fact, consistent with procedural norms for insider reporting.
FAQ
What transactions were reported on the ORGN Form 4 for John Hickox?
At what price were the RSUs for ORGN calculated?
Are the RSUs vested or subject to future vesting for ORGN's director?
How many shares does John Hickox beneficially own after the transaction?
When was the Form 4 signed and by whom?